Baolingbao Biology Co.,Ltd. (SHE:002286)
8.31
-0.13 (-1.54%)
Sep 2, 2026, 1:20 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.21 billion as of September 1, 2026. Its market cap has decreased by -24.55% in one year.
Market Cap
3.21B
Enterprise Value
3.08B
Revenue
2.85B
Ranking
n/a
PE Ratio
22.21
Stock Price
8.31
ChartMarket Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.21B, an increase of 77.79%. That is a compound annual growth rate of 3.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.21B | -5.59% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 3.41B |
| Shanghai Shen Lian Biomedical | 3.36B |
| Hinova Pharmaceuticals | 3.35B |
| Qingdao Vland Biotech INC. | 3.25B |
| Guanhao Biotech | 3.18B |
| Beijing Kawin Technology Share-Holding | 3.06B |
| Shanghai Model Organisms Center | 3.04B |
| Guangdong VTR Bio-Tech | 2.95B |